ArticleBMC ophthalmology2025
Clinical outcomes of pterygium surgery over a ten-year period: a review of recurrence and complication rates.
Article in BMC ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- A Retrospective Review of Glueless, Sutureless Pterygium Excision Using Biovance Triple-Layer Decellularized Amniotic Basement Membrane Tissue.Ophthalmology and therapy · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study described the clinical profile and post-operative outcomes of patients who underwent pterygium surgery at an ambulatory eye center in the Philippines over a ten-year period.
methodsThis retrospective study analyzed medical records of 462 eyes from 408 patients who underwent pterygium surgery by a single surgeon between February 2013 and August 2023. The study examined the clinical characteristics of patients with pterygium and evaluated the recurrence rates of three treatment methods: pterygium excision with conjunctival autograft (CAG), pterygium excision with dehydrated amniotic membrane graft (DAG), and primary excision with mitomycin C application. Descriptive statistics were used for analysis of patient demographics, clinical profile, and postoperative outcomes.
resultsThe mean patient age was 48 years (range 17-81), with a slight male predominance (57%). Nasal pterygium was the most common type (72%), followed by bipolar (8%) and temporal (3%) pterygium. Most cases were primary (81%), with T2G1 being the most common grading. Conjunctival autograft was the predominant surgical technique (94%), followed by dehydrated amniotic membrane graft (5%) and primary excision with mitomycin C application (1%). The overall recurrence rate was 1%, with conjunctival autograft showing the lowest rate, compared to dehydrated amniotic membrane graft and primary excision with mitomycin C. The complication rate was 4.5%, primarily minor findings such as conjunctival granuloma, wound dehiscence, and residual pterygium.
conclusionMost pterygium cases presented as primary and in the nasal area with T2G1 grading. This study supports conjunctival autograft as the preferred surgical technique for pterygium because of the low recurrence and complication rates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.